Primary Site >> Liver Cancer

Gene >> BCL9

  • 2007
  • 2013
  • 2015
  • 2017
  • 2018
Ref: Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis.
PMID: 17696935
Ref: Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
PMID: 23505090
Ref: Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma.
PMID: 23667372
Ref: [beta-Catenin: Structure, Function and Role in Malignant Transformation of Epithelial Cells].
PMID: 26710532
Ref: Hypoxia activates Wnt/beta-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma.
PMID: 28074862
Ref: Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer.
PMID: 28735896
Ref: miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/beta-catenin signaling through targeting BCL9.
PMID: 28817119
Ref: Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review).
PMID: 29786110